| Keywords: |
neutropenia; review; animal; liver toxicity; nephrotoxicity; regional perfusion; drug blood level; ketoconazole; immune deficiency; rifampicin; fluconazole; candidiasis; mycosis; antifungal agents; aspergillosis; intravenous drug administration; bone marrow toxicity; opportunistic infections; itraconazole; oral drug administration; flucytosine; coccidioidomycosis; histoplasmosis; mycoses; amphotericin b; cryptococcosis; miconazole; human; priority journal; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; mucormycosis
|
